Sulfur compounds block MCP-1 production by Mycoplasma fermentans-infected macrophages through NF-κB inhibition

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Benedetti, Francesca ^a,b   Davinelli, Sergio ^a,c   Krishnan, Selvi ^a   Gallo, Robert C ^a   Scapagnini, Giovanni ^c   Zella, Davide ^a   Curreli, Sabrina ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF MOLISE   (Italy)

Author keywords

GYY4137; Hydrogen sulfide (H2S); MCP 1; Monocytes macrophages; Mycoplasma fermentans; NaHS; NF B

Indexed keywords

ANTIINFLAMMATORY AGENT; GYY 4137; HYDROGEN SULFIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE ELASTASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MORPHOLIN 4 IUM 4 METHOXYPHENYL (MORPHOLINO) PHOSPHINODITHIOATE; SODIUM HYDROSULFIDE; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; PRIMER DNA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MACROPHAGE; MYCOPLASMA FERMENTANS; MYCOPLASMOSIS; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DRUG EFFECTS; ENZYME INDUCTION; METABOLISM; MICROBIOLOGY; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; U937 CELL LINE;

BASE SEQUENCE; CHEMOKINE CCL2; DNA PRIMERS; ENZYME INDUCTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYDROGEN SULFIDE; MACROPHAGES; MATRIX METALLOPROTEINASE 12; MYCOPLASMA FERMENTANS; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; U937 CELLS;

EID: 84902083120     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-145     Document Type: Article

References (52)

1. Li L, Rose P, Moore PK. Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol 2011, 51:169-187. 10.1146/annurev-pharmtox-010510-100505, 21210746.
2. Predmore BL, Lefer DJ, Gojon G. Hydrogen sulfide in biochemistry and medicine. Antioxid Redox Signal 2012, 17(1):119-140. 10.1089/ars.2012.4612, 3342665, 22432697.
3. Szabó C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007, 6(11):917-935. 10.1038/nrd2425, 17948022.
4. Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S, Moore PK. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 2006, 316(12):670-678.
5. Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z, Jeschke MG, Branski LK, Herndon DN, Wang R, Szabó C. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA 2009, 106(51):21972-21977. 10.1073/pnas.0908047106, 2799889, 19955410.
6. Bucci M, Papapetropoulos A, Vellecco V, Zhou Z, Pyriochou A, Roussos C, Roviezzo F, Brancaleone V, Cirino G. Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler Thromb Vasc Biol 2010, 30(10):1998-2004. 10.1161/ATVBAHA.110.209783, 20634473.
7. Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 2001, 20(21):6008-6016. 10.1093/emboj/20.21.6008, 125693, 11689441.
8. Grambow E, Mueller Graf F, Delyagina E, Frank M, Kuhla A, Vollmar B. Effect of the hydrogen sulfide donor GYY4137 on platelet activation and microvascular thrombus formation in mice. Platelets 2013, 25(3):166-174. Epub ahead of print.
9. Mirandola P, Gobbi G, Sponzilli I, Pambianco M, Malinverno C, Cacchioli A, De Panfilis G, Vitale M. Exogenous hydrogen sulfide induces functional inhibition and cell death of cytotoxic lymphocytes subsets. J Cell Physiol 2007, 213(3):826-833. 10.1002/jcp.21151, 17516567.
10. Fox B, Schantz JT, Haigh R, Wood ME, Moore PK, Viner N, Spencer JP, Winyard PG, Whiteman M. Inducible hydrogen sulfide synthesis in chondrocytes and mesenchymal progenitor cells: is H2S a novel cytoprotective mediator in the inflamed joint?. J Cell Mol Med 2012, 16(4):896-910. 10.1111/j.1582-4934.2011.01357.x, 3822858, 21679296.
11. Whiteman M, Winyard PG. Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. Exp Rev Clin Pharmacol 2011, 4(1):13-32.
12. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 2006, 20(12):2118-2120. 10.1096/fj.06-6270fje, 16912151.
13. Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, Jeon SB, Jeon WK, Chae HJ, Chung HT. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med 2006, 41(1):106-119. 10.1016/j.freeradbiomed.2006.03.021, 16781459.
14. Pan LL, Liu XH, Gong QH, Wu D, Zhu YZ. Hydrogen sulfide attenuated tumor necrosis factor-α-induced inflammatory signaling and dysfunction in vascular endothelial cells. PLoS One 2011, 6(5):e19766. 10.1371/journal.pone.0019766, 3091882, 21572963.
15. Lee M, Schwab C, Yu S, McGeer E, McGeer PL. Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol Aging 2009, 30(10):1523-1534. 10.1016/j.neurobiolaging.2009.06.001, 19631409.
16. Hu LF, Wong PT, Moore PK, Bian JS. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem 2007, 100(4):1121-1128. 10.1111/j.1471-4159.2006.04283.x, 17212697.
17. Li L, Salto-Tellez M, Tan CH, Whiteman M, Moore PK. GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. Free Radic Biol Med 2009, 47(1):103-113. 10.1016/j.freeradbiomed.2009.04.014, 19375498.
18. Peake BF, Nicholson CK, Lambert JP, Hood RL, Amin H, Amin S, Calvert JW. Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner. Am J Physiol Heart Circ Physiol 2013, 304(9):1215-1224.
19. Kaspar JW, Niture SK, Jaiswal AK. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 2009, 47(9):1304-1309. 10.1016/j.freeradbiomed.2009.07.035, 2763938, 19666107.
20. Merighi S, Gessi S, Varani K, Fazzi D, Borea PA. Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. Pharmacol Res 2012, 66(5):428-436. 10.1016/j.phrs.2012.07.002, 22842066.
21. Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 1998, 62(4):1094-1156. 98941, 9841667.
22. Rottem S. Interaction of mycoplasmas with host cells. Physiol Rev 2003, 83(2):417-432.
23. Seya T, Matsumoto M. A lipoprotein family from Mycoplasma fermentans confers host immune activation through Toll-like receptor 2. Int J Biochem Cell Biol 2002, 34(8):901-906. 10.1016/S1357-2725(01)00164-9, 12007626.
24. Kawahito Y, Ichinose S, Sano H, Tsubouchi Y, Kohno M, Yoshikawa T, Tokunaga D, Hojo T, Harasawa R, Nakano T, Matsuda K. Mycoplasma fermentans glycolipid-antigen as a pathogen of rheumatoid arthritis. Biochem Biophys Res Commun 2008, 369(2):561-566. 10.1016/j.bbrc.2008.02.079, 18307980.
25. Gilroy CB, Keat A, Taylor-Robinson D. The prevalence of Mycoplasma fermentans in patients with inflammatory arthritides. Rheumatology 2001, 40(12):1355-1358. 10.1093/rheumatology/40.12.1355, 11752504.
26. Yáñez A, Martínez-Ramos A, Calixto T, González-Matus FJ, Rivera-Tapia JA, Giono S, Gil C, Cedillo L. Animal model of Mycoplasma fermentans respiratory infection. BMC Res Notes 2013, 8:6-9.
27. Afriat R, Horowitz S, Priel E. Mycoplasma fermentans inhibits the activity of cellular DNA topoisomerase I by activation of PARP1 and alters the efficacy of its anti-cancer inhibitor. PLoS One 2013, 8(8):e72377. 10.1371/journal.pone.0072377, 3754970, 24013388.
28. Rawadi G, Roman-Roman S. Mycoplasma membrane lipoproteins induced proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide. Infect Immun 1996, 64(12):637-643. 173813, 8550219.
29. Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 1989, 244(2):487-493. 10.1016/0014-5793(89)80590-3, 2465924.
30. Fuentes ME, Durham SK, Swerdel MR, Lewin AC, Barton DS, Megill JR, Bravo R, Lira SA. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 1995, 155(12):5769-5776.
31. Gu L, Tseng SC, Rollins BJ. Monocyte chemoattractant protein-1. Chem Immunol 1999, 72:7-29.
32. Sørensen TL, Ransohoff RM, Strieter RM, Sellebjerg F. Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis. Eur J Neurol 2004, 11(7):445-449. 10.1111/j.1468-1331.2004.00796.x, 15257681.
33. Hayashida K, Nanki T, Girschick H, Yavuz S, Ochi T, Lipsky PE. Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8. Arthritis Res 2001, 3(2):118-126. 10.1186/ar149, 17828, 11178119.
34. Kusano KF, Nakamura K, Kusano H, Nishii N, Banba K, Ikeda T, Hashimoto K, Yamamoto M, Fujio H, Miura A, Ohta K, Morita H, Saito H, Emori T, Nakamura Y, Kusano I, Ohe T. Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis. Circ J 2004, 68(7):671-676. 10.1253/circj.68.671, 15226634.
35. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 2003, 100(12):7265-7270. 10.1073/pnas.1133870100, 165864, 12756299.
36. Lai JF, Zindl CL, Duffy LB, Atkinson TP, Jung YW, van Rooijen N, Waites KB, Krause DC, Chaplin DD. Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae. PLoS One 2010, 5(12):e14417. 10.1371/journal.pone.0014417, 3009709, 21203444.
37. Rawadi G. Mycoplasma fermentans interaction with monocytes/macrophages: molecular basis. Microbes Infect 2000, 2(8):955-964. 10.1016/S1286-4579(00)00395-6, 10962279.
38. Kaufmann A, Mühlradt PF, Gemsa D, Sprenger H. Induction of cytokines and chemokines in human monocytes by Mycoplasma fermentans-derived lipoprotein MALP-2. Infect Immun 1999, 67(12):6303-6308. 97033, 10569741.
39. Yadav A, Saini V, Arora S. MCP-1: Chemoattractant with a role beyond immunity: A review. Clin Chim Acta 2010, 411(21-22):1570-1579.
40. Dean RA, Cox JH, Bellac CL, Doucet A, Starr AE, Overall CM. Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR + CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood 2008, 112(8):3455-3464. 10.1182/blood-2007-12-129080, 18660381.
41. Li L, Whiteman M, Guan YY, Neo KL, Cheng Y, Lee SW, Zhao Y, Baskar R, Tan CH, Moore PK. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation 2008, 117(18):2351-2360. 10.1161/CIRCULATIONAHA.107.753467, 18443240.
42. Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem 1997, 272(49):31092-31099. 10.1074/jbc.272.49.31092, 9388261.
43. Won K, Kim SM, Lee SA, Rhim BY, Eo SK, Kim K. Multiple Signaling Molecules are Involved in Expression of CCL2 and IL-1 in Response to FSL-1, a Toll-Like Receptor 6 Agonist, in Macrophages. Korean J Physiol Pharmacol 2012, 16(6):447-453. 10.4196/kjpp.2012.16.6.447, 3526750, 23271927.
44. Sacht G, Marten A, Deiters U, Submuth R, Jung G, Wingender E, Muhlradt PF. Activation of nuclear factor-kB in macrophages by mycoplasmal lipopeptides. Eur J Immunol 1998, 28(12):4207-4212. 10.1002/(SICI)1521-4141(199812)28:12<4207::AID-IMMU4207>3.0.CO;2-R, 9862357.
45. Hawkins RE, Rickman LS, Vermund SH, Carl M. Association of Mycoplasma and human immunodeficiency virus infection: detection of amplified Mycoplasma fermentans DNA in blood. J Infect Dis 1992, 165(3):581-585. 10.1093/infdis/165.3.581, 1538164.
46. You XX, Zeng YH, Wu YM. Interactions between mycoplasma lipid-associated membrane proteins and the host cells. J Zhejiang Univ Sci B 2006, 7(5):342-350. 10.1631/jzus.2006.B0342, 1462930, 16615163.
47. Liu YC, Lin IH, Chung WJ, Hu WS, Ng WV, Lu CY, Huang TY, Shu HW, Hsiao KJ, Tsai SF, Chang CH, Lin CH. Proteomics characterization of cytoplasmic and lipid-associated membrane proteins of human pathogen Mycoplasma fermentans M64. PLoS One 2012, 7(4):e35304. 10.1371/journal.pone.0035304, 3335035, 22536369.
48. Bossink AW, Paemen L, Jansen PM, Hack CE, Thijs LG, Van Damme J. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood 1995, 86(10):3841-3847.
49. Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J Clin Invest 2001, 107(1):7-11. 10.1172/JCI11830, 198552, 11134171.
50. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002, 2(10):725-734. 10.1038/nri910, 12360211.
51. Baeuerle PA, Baichwal VR. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 1997, 65:111-137.
52. Sen N, Paul BD, Gadalla MM, Mustafa AK, Sen T, Xu R, Kim S, Snyder SH. Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions. Mol Cell 2012, 45(1):13-24. 10.1016/j.molcel.2011.10.021, 3261430, 22244329.